| 1 |
30717701 | Evaluation of the antioxidant effects of different histone deacetylase inhibitors (HDACis) on human lens epithelial cells (HLECs) after UVB exposure. | 2019 Feb 4 |
1 |
| 2 |
31100944 | Application of Electric Cell-Substrate Impedance Sensing to Investigate the Cytotoxic Effects of Andrographolide on U-87 MG Glioblastoma Cell Migration and Apoptosis. | 2019 May 16 |
1 |
| 3 |
29959912 | SAHA and cisplatin sensitize gastric cancer cells to doxorubicin by induction of DNA damage, apoptosis and perturbation of AMPK-mTOR signalling. | 2018 Sep 15 |
1 |
| 4 |
30018745 | BET inhibition in advanced cutaneous T cell lymphoma is synergistically potentiated by BCL2 inhibition or HDAC inhibition. | 2018 Jun 26 |
1 |
| 5 |
30091530 | ING5-mediated antineuroblastoma effects of suberoylanilide hydroxamic acid. | 2018 Sep |
1 |
| 6 |
27488871 | Induction of Apoptosis in Intestinal Toxicity to a Histone Deacetylase Inhibitor in a Phase I Study with Pelvic Radiotherapy. | 2017 Apr |
1 |
| 7 |
28109246 | Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis. | 2017 Jan 21 |
1 |
| 8 |
26228975 | Suberoylanilide Hydroxamic Acid, an Inhibitor of Histone Deacetylase, Induces Apoptosis in Rheumatoid Arthritis Fibroblast-Like Synoviocytes. | 2016 Feb |
1 |
| 9 |
26936390 | The levels of HDAC1 and thioredoxin1 are related to the death of mesothelioma cells by suberoylanilide hydroxamic acid. | 2016 May |
1 |
| 10 |
25370819 | The synergistic effect of SAHA and parthenolide in MDA-MB231 breast cancer cells. | 2015 Jun |
1 |
| 11 |
25963741 | Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma. | 2015 Aug |
1 |
| 12 |
26555243 | Novel β-Carboline/Hydroxamic Acid Hybrids Targeting Both Histone Deacetylase and DNA Display High Anticancer Activity via Regulation of the p53 Signaling Pathway. | 2015 Dec 10 |
1 |
| 13 |
24618889 | Epigenetic silencing of apoptosis-inducing gene expression can be efficiently overcome by combined SAHA and TRAIL treatment in uterine sarcoma cells. | 2014 |
1 |
| 14 |
24626405 | Suberoylanilide hydroxamic acid-induced HeLa cell death is closely correlated with oxidative stress and thioredoxin 1 levels. | 2014 May |
1 |
| 15 |
25261655 | Effects and mechanism of suberoylanilide hydroxamic acid on the proliferation and apoptosis of human hepatoma cell line Bel-7402. | 2014 Jul-Sep |
2 |
| 16 |
25546354 | Effects of suberoylanilide hydroxamic acid (SAHA) combined with paclitaxel (PTX) on paclitaxel-resistant ovarian cancer cells and insights into the underlying mechanisms. | 2014 |
1 |
| 17 |
24236158 | The anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) on the aggressive phenotypes of ovarian carcinoma cells. | 2013 |
1 |
| 18 |
22093617 | Requirement of p38 MAPK for a cell-death pathway triggered by vorinostat in MDA-MB-231 human breast cancer cells. | 2012 Feb 28 |
1 |
| 19 |
23086637 | [Synergistic effect of histone deacetylase inhibitor suberoylanilide hydroxamic acid with imatinib on K562 cells]. | 2012 Sep |
1 |
| 20 |
21695163 | Vorinostat induces reactive oxygen species and DNA damage in acute myeloid leukemia cells. | 2011 |
1 |
| 21 |
19911379 | Suberoylanilide hydroxamic acid (SAHA) at subtoxic concentrations increases the adhesivity of human leukemic cells to fibronectin. | 2010 Jan 1 |
1 |
| 22 |
20596669 | Anticancer effects of the MHY218 novel hydroxamic acid-derived histone deacetylase inhibitor in human ovarian cancer cells. | 2010 Aug |
1 |
| 23 |
21472287 | Synergistic induction of apoptosis in HeLa cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitor SAHA. | 2010 Jul-Aug |
1 |
| 24 |
19643600 | The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation. | 2009 Sep |
1 |
| 25 |
18005386 | Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma. | 2008 Feb |
1 |
| 26 |
18343280 | Temsirolimus downregulates p21 without altering cyclin D1 expression and induces autophagy and synergizes with vorinostat in mantle cell lymphoma. | 2008 Apr |
1 |
| 27 |
17351739 | SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib. | 2007 Jul |
1 |
| 28 |
17390020 | Chemosensitization of oral squamous cell carcinoma cells to cisplatin by histone deacetylase inhibitor, suberoylanilide hydroxamic acid. | 2007 May |
1 |
| 29 |
17493329 | [Histone deacetylase inhibitor SAHA induces inactivation of MAPK signaling and apoptosis in HL-60 cells]. | 2007 Apr |
2 |
| 30 |
17681667 | Combined effects of histone deacetylase inhibitor and rituximab on non-Hodgkin's B-lymphoma cells apoptosis. | 2007 Dec |
1 |
| 31 |
18025281 | Histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis through both mitochondrial and Fas (Cd95) signaling in head and neck squamous carcinoma cells. | 2007 Nov |
1 |
| 32 |
18025282 | Synergistic activity of the histone deacetylase inhibitor suberoylanilide hydroxamic acid and the bisphosphonate zoledronic acid against prostate cancer cells in vitro. | 2007 Nov |
2 |
| 33 |
16458111 | Histone deacetylase inhibitors require caspase activity to induce apoptosis in lung and prostate carcinoma cells. | 2006 Feb 8 |
1 |
| 34 |
16550602 | The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL. | 2006 Aug 15 |
1 |
| 35 |
16834771 | Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients. | 2006 Jul 11 |
1 |
| 36 |
17016591 | Histone deacetylase inhibitors induce cell death in supratentorial primitive neuroectodermal tumor cells. | 2006 Nov |
1 |
| 37 |
15625278 | Cotreatment with suberanoylanilide hydroxamic acid and 17-allylamino 17-demethoxygeldanamycin synergistically induces apoptosis in Bcr-Abl+ Cells sensitive and resistant to STI571 (imatinib mesylate) in association with down-regulation of Bcr-Abl, abrogation of signal transducer and activator of transcription 5 activity, and Bax conformational change. | 2005 Apr |
1 |
| 38 |
15781658 | Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species. | 2005 Mar 15 |
2 |
| 39 |
16297208 | Selective induction of apoptosis by histone deacetylase inhibitor SAHA in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. | 2005 Nov |
2 |
| 40 |
15596714 | Apoptotic and autophagic cell death induced by histone deacetylase inhibitors. | 2004 Dec 28 |
2 |
| 41 |
12893773 | The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571. | 2003 Nov 15 |
2 |
| 42 |
14679005 | Coadministration of the heat shock protein 90 antagonist 17-allylamino- 17-demethoxygeldanamycin with suberoylanilide hydroxamic acid or sodium butyrate synergistically induces apoptosis in human leukemia cells. | 2003 Dec 1 |
1 |
| 43 |
12094258 | Synergistic induction of mitochondrial damage and apoptosis in human leukemia cells by flavopiridol and the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA). | 2002 Jul |
1 |
| 44 |
10597302 | Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53. | 1999 Nov 25 |
1 |